Letermovir for the Prevention of CMV Infection in HSCT Recipients Based on the Outcome of mNGS
NCT06021210
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
80
Enrollment
OTHER
Sponsor class
Conditions
CMV Infection
Hematopoietic Stem Cell Transplantation
Interventions
DRUG:
Letermovir Pill
Sponsor
The First Affiliated Hospital of Soochow University